Alector, Inc. — Investor Relations & Filings
Filings indexed
558
across all filing types
Latest filing
2026-05-07
Regulatory Filings
Country
US
United States of America
Listing
US
ALEC
Alector, Inc. is a clinical-stage biotechnology company that develops therapies for neurodegenerative diseases. The company pioneers an approach known as immuno-neurology, which utilizes the body's immune system to address brain disorders. By integrating insights from human genetics, neuroscience, and immunology, Alector is advancing a pipeline of potential first-in-class and best-in-class medicines. Its therapeutic candidates are designed to treat conditions such as Alzheimer's disease and frontotemporal dementia by removing toxic proteins, replacing deficient proteins, and restoring the function of immune and nerve cells. The company's primary mission is to slow the progression of neurodegenerative diseases and improve overall brain health.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Alector, Inc. (0001653087) (Filer) | 2026-05-07 | English | |
| 424B5 - Alector, Inc. (0001653087) (Filer) | 2026-05-07 | English | |
| SCHEDULE 13G/A - Alector, Inc. (0001653087) (Subject) | 2026-03-26 | English | |
| 4 - ALECTOR, INC. (0001653087) (Filer) | 2026-03-03 | English | |
| 4 - ALECTOR, INC. (0001653087) (Filer) | 2026-03-03 | English | |
| 4 - ALECTOR, INC. (0001653087) (Filer) | 2026-03-03 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 43582544 | 8-K - Alector, Inc. (0001653087) (Filer) | 2026-05-07 | English | ||
| 43582400 | 424B5 - Alector, Inc. (0001653087) (Filer) | 2026-05-07 | English | ||
| 33051721 | SCHEDULE 13G/A - Alector, Inc. (0001653087) (Subject) | 2026-03-26 | English | ||
| 32895933 | 4 - ALECTOR, INC. (0001653087) (Filer) | 2026-03-03 | English | ||
| 32895934 | 4 - ALECTOR, INC. (0001653087) (Filer) | 2026-03-03 | English | ||
| 32895935 | 4 - ALECTOR, INC. (0001653087) (Filer) | 2026-03-03 | English | ||
| 32895936 | 4 - ALECTOR, INC. (0001653087) (Filer) | 2026-03-03 | English | ||
| 32895937 | 4 - ALECTOR, INC. (0001653087) (Filer) | 2026-02-26 | English | ||
| 32895939 | 10-K - ALECTOR, INC. (0001653087) (Filer) | 2026-02-25 | English | ||
| 32895938 | 8-K - ALECTOR, INC. (0001653087) (Filer) | 2026-02-25 | English | ||
| 31149185 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31149162 | SCHEDULE 13G/A Filing | 2026-02-06 | English | ||
| 31149204 | SCHEDULE 13G/A Filing | 2026-01-30 | English | ||
|
2025
2 filings
| |||||
| 12908328 | 8-K | 2025-12-12 | English | ||
| 12908333 | Director's Dealing 2025 | 2025-12-08 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cohance Lifesciences Limited
Global CDMO and API platform offering end-to-end solutions …
|
COHANCE | IN | Manufacturing |
|
Coherus Oncology, Inc.
Biopharmaceutical company developing and commercializing im…
|
CHRS | US | Manufacturing |
|
Colinz Laboratories ltd.
Manufactures and markets medicinal formulations across dive…
|
531210 | IN | Manufacturing |
|
COLLEGIUM PHARMACEUTICAL, INC
A biopharmaceutical company developing abuse-deterrent pain…
|
COLL | US | Manufacturing |
|
CollPlant Biotechnologies Ltd
Develops plant-derived collagen for 3D bioprinting of tissu…
|
CLGN | US | Manufacturing |
|
COMPASS Pathways plc
Develops psilocybin treatments for difficult-to-treat menta…
|
CMPS | GB | Manufacturing |
|
Compass Therapeutics, Inc.
Clinical-stage biopharma developing antibody-based therapeu…
|
CMPX | US | Manufacturing |
|
Concord Biotech Limited
R&D-driven producer of fermentation-based APIs and formulat…
|
CONCORDBIO | IN | Manufacturing |
|
Concord Drugs Limited
Develops, manufactures and markets pharmaceutical formulati…
|
538965 | IN | Manufacturing |
|
ConjuChem Biotechnologies Inc.
Develops long-acting therapeutic peptides using proprietary…
|
CJHMF | CA | Manufacturing |
Alector, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33290/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33290 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33290 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33290 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33290}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Alector, Inc. (id: 33290)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.